~~<i id='5D22D1AE93'><strike id='5D22D1AE93'><tt id='5D22D1AE93'><pre id='5D22D1AE93'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：Wikipedia 2025-08-25 16:33:34 - browse：75433

Adam's take main illustration — Molly Ferguson/STAT

Biotech is awash in PIPEs.

The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Paxlovid rebound happens. Why and to whom are still a mystery

hotspot

focus

leisure time

focus

entertainment

knowledge

ROME--Hometownpassionforthisyear’ssoccerchampionsfromNapleshasbetrayedthehideoutofalongtimecrimefugi

WSS

It's time to retire 'poor historian' from clinicians' vocabularies

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Doctors are clamoring for more clarity on Paxlovid prescribing

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

'Brian's Song' at 50 still offers lessons about cancer for today

Election results set back Medicaid expansion plans

focus

hotspot

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

It's time to retire 'poor historian' from clinicians' vocabularies

Medical leaders decry Supreme Court decision on affirmative action

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Doctors are clamoring for more clarity on Paxlovid prescribing

Trump demands the U.S. pay no more for drugs than other countries … again

Kansas bar where gunfire wounded 9 last month closes permanently

Heart attack and stroke risk calculators need revising

Sage considers ways to reduce costs following FDA rejection

focus

With measles on the rise, a personal story of a devastating disease

With measles on the rise, a personal story of a devastating disease

Sweden knocks USA out of World Cup in penalty kicks

Judge in Trump's classified documents case questions use of out

Case highlights the risks of experimental stem cell therapy

Slovenia has suffered its worst

leisure time

focus

entertainment

knowledge